MacroGenics
Price & Volume
Stats
See moreOpen | $2.80 |
Previous Close | $2.86 |
Day Range | $2.79-$2.87 |
52W Range | $2.34-$21.88 |
Market Cap | $179.5M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $141.3M |
Revenue Growth (YoY) | 964.8% |
Gross Profit (12 Mos) | -$51.2M |
Diluted EPS | -$1.57 |
News
See moreYahoo Finance • 13 days ago
Investigation Alert: MacroGenics, Apellis Pharmaceuticals, Teradata and Maplebear - Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
Yahoo Finance • 9 months ago
Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)
Yahoo Finance • last year
Shareholders in MacroGenics (NASDAQ:MGNX) are in the red if they invested three years ago
Yahoo Finance • last year
MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results
About
CEO | Dr. Scott Koenig M.D., Ph.D. |
CFO | Mr. James Karrels |
Address | 9704 Medical Center Drive, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 339 |
